Loading…
Illumina, Inc. is projected to rise to $244.11 by 2027, a +28% move from its current price of $190.20. ILMN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $186.04 | $190.25 | $194.55 | +0.03% |
| Jul 14 | $184.37 | $190.30 | $196.42 | +0.05% |
| Jul 15 | $183.11 | $190.35 | $197.87 | +0.08% |
| Jul 16 | $182.06 | $190.40 | $199.11 | +0.10% |
| Jul 17 | $181.15 | $190.44 | $200.22 | +0.13% |
| Jul 18 | $180.33 | $190.49 | $201.23 | +0.15% |
| Jul 19 | $179.59 | $190.54 | $202.16 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $179.59 | $190.54 | $202.16 | +0.18% |
| Week 2 | $175.55 | $190.88 | $207.56 | +0.36% |
| Week 3 | $172.59 | $191.23 | $211.88 | +0.54% |
| Week 4 | $170.18 | $191.57 | $215.66 | +0.72% |
| Week 5 | $168.12 | $191.92 | $219.08 | +0.90% |
| Week 6 | $166.31 | $192.26 | $222.27 | +1.08% |
| Week 7 | $164.68 | $192.61 | $225.27 | +1.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Illumina, Inc. is a healthcare company that provides sequencing- and array-based solutions for genetic and genomic analysis across the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest.
Illumina also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors.
It has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease.
Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Illumina, Inc. (ILMN) is currently priced at $188.68 per share, with a market capitalization of $28.55B, and it ranks 458. The near-term forecast for 2026 shows a neutral stance with a min of $114.44, an avg of $188.68, and a max of $250.87, and a 0% ROI.
From 2027 onward, the outlook shifts to bullish, with rising averages and positive ROIs through the forecast horizon.
Over the longer term, the average price is projected to climb, with the 2027 avg at $248.41 and the 2050 avg at $3,223.67, while the max forecasts rise to $5,633.91 by 2050. These figures imply a sustained bullish trajectory across the majority of the forecast years.
A major floor 39.2% below — a decisive break under it would weaken the trend.
The nearest floor, 16.9% below — buyers have tended to step in here.
Price is pressing into resistance (2.2% away) — a breakout level to watch.
A major ceiling 14.2% above — clearing it would confirm fresh momentum.
Key ILMN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ILMN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $191.57 | Sell | $189.95 | Buy |
| MA 10 | $186.39 | Buy | $185.99 | Buy |
| MA 20 | $176.12 | Buy | $178.49 | Buy |
| MA 50 | $159.32 | Buy | $163.28 | Buy |
| MA 100 | $142.32 | Buy | $150.12 | Buy |
| MA 200 | $132.47 | Buy | $136.86 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.86 | Neutral |
| Stoch RSI (14) | 49.45 | Neutral |
| CCI (20) | 89.79 | Neutral |
| Williams %R (14) | -12.53 | Info |
| MACD (12,26,9) | 0.88 | Buy |
| ROC (12) | 15.32 | Buy |
| Bollinger %B (20,2) | 0.79 | Neutral |
| Stochastic %K (14) | 87.47 | Sell |
| TRIX (15) | 0.78 | Buy |
| Awesome (5,34) | 22.82 | Buy |
| Ultimate (7,14,28) | 70.04 | Sell |
| Momentum (10) | 12.55 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 193.17 | Sell |
| ADX (14) | 31.95 | Buy |
| ATR (14) | 4.17 | Info |
The 30-day technical picture shows bullish sentiment overall. RSI14 is at 70, and the stock trades above the 50-day simple moving average ($SMA50$) of $152.95 and the 200-day simple moving average ($SMA200$) of $130.23, signaling constructive near-term momentum.
Support is identified at $141.92 and resistance at $188.68, with a 30-day price range spanning $161.82 to $220.00. The stock’s annualized volatility is 40%, reflecting the level of variability in the price over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $114.44 | $190.20 | $250.74 | 0% | Neutral | |
| $197.59 | $244.11 | $316.95 | +28% | Bullish | |
| $220.20 | $278.20 | $372.63 | +46% | Bullish | |
| $268.26 | $345.25 | $473.89 | +82% | Bullish | |
| $341.55 | $446.77 | $626.03 | +135% | Bullish | |
| $391.45 | $519.66 | $741.46 | +173% | Bullish | |
| $437.97 | $589.43 | $854.80 | +210% | Bullish | |
| $480.87 | $655.50 | $964.76 | +245% | Bullish | |
| $527.34 | $727.61 | $1,085.58 | +283% | Bullish | |
| $563.41 | $786.42 | $1,188.30 | +313% | Bullish | |
| $973.84 | $1,431.77 | $2,282.13 | +653% | Bullish | |
| $1,791.72 | $2,875.25 | $4,957.57 | +14.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $114.44 | $190.20 | $229.00 | +0.00% |
| August 2026 | $164.08 | $192.72 | $231.75 | +1.32% |
| September 2026 | $164.83 | $194.71 | $236.30 | +1.03% |
| October 2026 | $170.31 | $202.17 | $247.28 | +3.84% |
| November 2026 | $171.88 | $204.88 | $252.22 | +1.34% |
| December 2026 | $169.20 | $202.47 | $250.74 | -1.18% |
Click any year to see its month-by-month ILMN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ILMN price prediction for 2026 points to an average of $190.20 (low $114.44, high $250.74) — a potential gain of 0% on today's $190.20. A consolidation phase looks the most probable path here.
In 2027, ILMN is projected to trade between $197.59 and $316.95, averaging $244.11 — a potential gain of +28% from today's $190.20. That is up +28% on the projected 2026 average. Momentum favours further upside here.
Illumina, Inc.'s 2028 outlook centres on $278.20, within a $220.20 to $372.63 range. That is up +14% on the projected 2027 average. That marks a +46% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, ILMN could reach as high as $473.89, with a base case around $345.25 and support toward $268.26 — roughly +82% from $190.20. Momentum favours further upside here.
Expect ILMN to range from $341.55 to $626.03 through 2030. The $446.77 average target implies a +135% move from current prices. That is up +29% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The ILMN price prediction for 2031 points to an average of $519.66 (low $391.45, high $741.46) — a potential gain of +173% on today's $190.20. Momentum favours further upside here.
In 2032, ILMN is projected to trade between $437.97 and $854.80, averaging $589.43 — a potential gain of +210% from today's $190.20. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Illumina, Inc.'s 2033 outlook centres on $655.50, within a $480.87 to $964.76 range. That is up +11% on the projected 2032 average. That marks a +245% change versus current levels. Momentum favours further upside here.
By 2034, ILMN could reach as high as $1,085.58, with a base case around $727.61 and support toward $527.34 — roughly +283% from $190.20. Buyers look set to stay in control over this stretch.
Expect ILMN to range from $563.41 to $1,188.30 through 2035. The $786.42 average target implies a +313% move from current prices. That is up +8% on the projected 2034 average. Momentum favours further upside here.
The ILMN price prediction for 2040 points to an average of $1,431.77 (low $973.84, high $2,282.13) — a potential gain of +653% on today's $190.20. Buyers look set to stay in control over this stretch.
In 2050, ILMN is projected to trade between $1,791.72 and $4,957.57, averaging $2,875.25 — a potential gain of +14.1x from today's $190.20. That is up +101% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ILMN today (≈ 5.257624 ILMN) could be worth
$15,116.98
+$14,116.98 (+1412%) by 2050 · US Dollar
Based on the average projected ILMN price of $2,875.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ILMNwould be worth at today's price.
$1,000 invested in ILMN on Jul 10, 2025 (≈ 9.995002 ILMN) would be worth
$1,901.05
+$901.05 (+90.1%) today · 1.90× · US Dollar
Based on a ILMN entry price of $100.05 vs. today's $190.2.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $188.68 | $1,008.06 | +0.8% |
| 1 month ago | $162.47 | $1,170.68 | +17.1% |
| 3 months ago | $120.93 | $1,572.81 | +57.3% |
| 6 months ago | $145.55 | $1,306.77 | +30.7% |
| 1 year ago | $100.05 | $1,901.05 | +90.1% |
| All time (5.0y) ago | $470.35 | $404.38 | -59.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ILMN forecast.
Our base-case forecast reaches $380.00 around 2030.
Implied market cap at $380.00: $57.49B
The multi-year forecast depicts a clear bullish trajectory. The 2026 min/max/avg prices are $114.44 / $188.68 / $188.68, with an average price of $188.68 and 0% ROI. As the years progress, the average price rises to $248.41 (2027), $283.49 (2028), $359.44 (2029), $474.41 (2030), $544.31 (2031), $624.23 (2032), $705.35 (2033), $771.83 (2034), and $844.15 (2035).
Looking further, the 2040 average is projected at $1,563.33 and the 2050 average at $3,223.67, with a max of $2,520.26 in 2040 and $5,633.91 in 2050. The corresponding ROI peaks at 728.6% in 2040 and 1608.5% in 2050, with sentiment remaining BULLISH across the horizon. These are estimates and not guarantees, reflecting potential upside but carrying uncertainty.
Tap a question to reveal the answer.
For 2030, the forecast shows min $360.47, avg $474.41, max $669.77, with ROI 151.4% and sentiment BULLISH.
The forecast indicates bullish sentiment in most years after 2026, with rising averages and positive ROIs (e.g., 2027 avg $248.41 with 31.7% ROI; 2028 avg $283.49 with 50.3% ROI; 2029 avg $359.44 with 90.5% ROI). However, 2026 is neutral with an average price of $188.68 and ROI of 0%.
Yes. The forecast max reaches $1,047.54 in 2033 and $1,162.46 in 2034, with further upside in later years (e.g., 2040 max $2,520.26 and 2050 max $5,633.91). These are estimates, not guarantees.
Market cap is $28.55B and it is ranked 458.
Illumina, Inc. Community Discussion
0Share your Illumina, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.